Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.76% is in line with its 5-year average of 96.94%, near the high end of its 5-year range (33.33%–100.00%).
0.03% above its 12-month average of 99.73%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
99.76%
GROSS MARGIN AVG TTM
99.73%
GROSS MARGIN AVG 3Y
92.73%
GROSS MARGIN AVG 5Y
96.94%
GROSS MARGIN AVG 10Y
95.08%
GROSS MARGIN AVG 15Y
90.18%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.03%
CURRENT VS 3Y AVG
+7.58%
CURRENT VS 5Y AVG
+2.91%
CURRENT VS 10Y AVG
+4.92%
CURRENT VS 15Y AVG
+10.62%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.08%
vs the sector median at left
Ironwood Pharmaceuticals, Inc.
Market Cap
$601.84M
Gross Margin
99.76%
TTM Avg
99.73%
3Y Avg
92.73%
5Y Avg
96.94%
Market Cap
$594.45M
Gross Margin
54.62%
TTM Avg
54.27%
3Y Avg
52.72%
5Y Avg
52.86%
Market Cap
$585.90M
Gross Margin
35.58%
TTM Avg
39.19%
3Y Avg
43.45%
5Y Avg
55.13%
Market Cap
$583.51M
Gross Margin
73.65%
TTM Avg
72.81%
3Y Avg
73.64%
5Y Avg
74.48%
Market Cap
$577.78M
Gross Margin
67.04%
TTM Avg
65.22%
3Y Avg
62.15%
5Y Avg
65.14%
Market Cap
$625.86M
Gross Margin
66.63%
TTM Avg
64.65%
3Y Avg
65.95%
5Y Avg
64.74%
Market Cap
$628.39M
Gross Margin
84.52%
TTM Avg
76.56%
3Y Avg
85.05%
5Y Avg
87.20%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals, Inc. (IRWD) | $601.84M | 99.76% | 99.73% | 92.73% | 96.94% |
| AngioDynamics, Inc. (ANGO)vs › | $594.45M | 54.62% | 54.27% | 52.72% | 52.86% |
| Climb Bio, Inc. (CLYM)vs › | $618.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fulgent Genetics, Inc. (FLGT)vs › | $585.90M | 35.58% | 39.19% | 43.45% | 55.13% |
| OrthoPediatrics Corp. (KIDS)vs › | $583.51M | 73.65% | 72.81% | 73.64% | 74.48% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $577.78M | 67.04% | 65.22% | 62.15% | 65.14% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $625.86M | 66.63% | 64.65% | 65.95% | 64.74% |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $628.39M | 84.52% | 76.56% | 85.05% | 87.20% |
| CorMedix Inc. (CRMD)vs › | $570.35M | 82.78% | 90.56% | 68.85% | 51.96% |
| OmniAb, Inc. (OABI)vs › | $635.70M | -18.17% | 40.91% | 70.46% | 80.30% |
Gross Margin
99.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 99.58% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 99.61% |
| 2025-06-30 | 99.45% |
| 2025-03-31 | 33.33% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 67.43% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 65.52% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 99.55% |
| 2023-06-30 | 81.58% |
| 2023-03-31 | 99.73% |
| 2022-12-31 | 99.68% |
| 2022-09-30 | 99.67% |
| 2022-06-30 | 99.63% |
| 2022-03-31 | 88.90% |
| 2021-12-31 | 99.69% |
| 2021-09-30 | 89.49% |
| 2021-06-30 | 88.31% |
| 2021-03-31 | 82.57% |
| 2020-12-31 | 99.23% |
| 2020-09-30 | 79.04% |
| 2020-06-30 | 99.28% |
| 2020-03-31 | 97.20% |
| 2019-12-31 | 91.28% |
| 2019-09-30 | 99.61% |
| 2019-06-30 | 88.93% |
| 2019-03-31 | 98.48% |
| 2018-12-31 | 83.58% |
| 2018-09-30 | 92.97% |
| 2018-06-30 | 94.99% |
| 2018-03-31 | 96.23% |
| 2017-12-31 | 90.31% |
| 2017-09-30 | 93.00% |
| 2017-06-30 | 94.62% |
| 2017-03-31 | 98.98% |
| 2016-12-31 | 97.86% |
| 2016-09-30 | 43.23% |
| 2016-06-30 | 41.71% |
| 2016-03-31 | 51.79% |
| 2015-12-31 | 84.71% |
| 2015-09-30 | 10.75% |
| 2015-06-30 | 70.62% |
| 2015-03-31 | 99.96% |
| 2014-12-31 | 65.48% |
| 2014-09-30 | -48.49% |
| 2014-06-30 | -53.77% |
| 2014-03-31 | 86.83% |
| 2013-12-31 | 89.41% |
| 2013-09-30 | 59.02% |
| 2013-06-30 | 64.63% |
| 2013-03-31 | 62.18% |
| 2012-12-31 | 96.42% |
| 2012-09-30 | 73.08% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
